SEC Contract Filing

Filing Date: 2021-07-30

Document Content:
<DOCUMENT>
<TYPE>EX-10.9
<SEQUENCE>5
<FILENAME>cydy-20210531xex10d9.htm
<DESCRIPTION>EX-10.9
<TEXT>
<!--Enhanced HTML document created with Toppan Merrill Bridge 9.11.0.85--><!--Created on: 7/30/2021 09:09:18 PM (UTC)--><!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head><meta charset="UTF-8"><title></title></head><body><div style="margin-top:30pt;"></div><div style="max-width:100%;padding-left:11.76%;padding-right:11.76%;position:relative;"><div style="margin-top:30pt;min-height:36pt;width:100%;"><p style="font-family:'Times';font-size:12pt;line-height:1.19;text-align:right;margin:0pt;"><b style="font-weight:bold;">Exhibit 10.9</b></p><p style="font-family:'Times';font-size:12pt;line-height:1.19;margin:0pt;"><font style="visibility:hidden;">&#8203;</font></p></div><div style="clear:both;max-width:100%;position:relative;"><p style="font-family:'Times';font-size:10pt;line-height:1.23;text-align:center;text-indent:0.8pt;margin:0.44pt 7.35pt 12pt 9.65pt;"><b style="font-family:'Arial','Helvetica','sans-serif';font-weight:bold;">CERTAIN IDENTIFIED INFORMATION MARKED BY [*] HAS BEEN EXCLUDED FROM THIS<br>EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE<br>COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED</b></p><p style="font-family:'Times';font-size:11pt;line-height:1.23;text-align:center;text-indent:0.8pt;margin:0.44pt 7.35pt 0pt 9.65pt;"><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Amendment</b><b style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';font-weight:bold;"> No.1 to </b><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Exclusive Supply and Distribution Agreement</b></p><p style="font-family:'Times';font-size:12pt;line-height:1.19;margin:0pt 0pt 0pt 46.45pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;margin-left:0pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times';font-size:11pt;line-height:1.23;text-align:justify;text-indent:0.8pt;margin:0.44pt 7.35pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';">This amendment (this &#8220;</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Amendment</b><font style="font-family:'Times New Roman','Times','serif';">&#8221;), dated as of April 19, 2021, is entered by and between </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">CytoDyn Inc., a Delaware corporation (&#8220;</font><b style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';font-weight:bold;">CytoDyn&#8221;</b><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">) having a place of business at 1111 Main Street, Vancouver, Washington 98660, and Chiral Pharma Corporation, a Philippines corporation (&#8220;</font><b style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';font-weight:bold;">CPC</b><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">&#8221;) having a place of business at P. Antonio St., cor F. Legaspi St., Ugong, Pasig, Metro Manila, with respect to the following</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-0.15pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">facts:</font></p><p style="font-family:'Times';font-size:12pt;line-height:1.19;margin:0.34pt 0pt 0pt 0pt;"><font style="font-family:'Times New Roman','Times','serif';font-size:11pt;visibility:hidden;">&#8203;</font></p><p style="font-family:'Times';font-size:11pt;line-height:1.19;margin:0pt;"><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">The parties entered into a certain </font><font style="font-family:'Times New Roman','Times','serif';">Exclusive Supply and Distribution Agreement dated as of April 15, 2021 </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">(</font><font style="font-family:'Times New Roman','Times','serif';">&quot;</font><b style="font-family:'Times New Roman','Times','serif';font-weight:bold;">Agreement</b><font style="font-family:'Times New Roman','Times','serif';">&quot;). Capitalized terms not defined herein have their respective meanings in the Agreement. </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">The parties now desire to amend the Agreement in certain respects on the terms and conditions set forth</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:0.25pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">below. In</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-1.55pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">consideration</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-0.45pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">of</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-1.1pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">the</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-1.3pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">foregoing</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-0.95pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">premises</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-0.95pt;"> </font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';">and</font><font style="color:#1d1d1d;font-family:'Times New Roman','Times','serif';letter-spacing:-1.05pt;"> </font><font sty